-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A reporter from Singapore TV Asia News: In the global vaccine competition, China's new crown vaccine has attracted much attention.
Guo Weimin: I think the two questions you just asked, one is the safety and effectiveness of the vaccine, and the other is about the purpose of vaccine export.
management
Guo Weimin: Regarding the first question, China has taken vaccine research and development as an important task after the start of the battle against the new crown epidemic.
Guo Weimin: The vaccines of Sinopharm and Beijing Kexing that were previously conditionally listed in China are all inactivated vaccines.
Guo Weimin: You asked about our purpose of exporting vaccines.
Coronavirus disease
Guo Weimin: As of the end of February, China has provided vaccine assistance to 69 countries and 2 international organizations, and exported vaccines to 28 countries.
Guo Weimin: At present, the new crown epidemic is still raging in many countries.
Leave a message here